Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2011

Effects Of Latanoprost Versus Travoprost With Sofzia On The Ocular Surface Of Patients

Shelly R. Gupta; Jonathan S. Myers; Cristobal C. Cruz; Tania Tai; Sheryl S. Wizov; Marlene R. Moster; Michael J. Pro; Christopher J. Rapuano; John R. Wittpenn; L. J. Katz

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):229.

ARVO Annual Meeting Abstract April 2010

Prevalence of Glistenings in Acrysof Intraocular Lenses

J. R. Wittpenn

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5454.

ARVO Annual Meeting Abstract April 2009

Effects of Xalatan® (Latanoprost Ophthalmic Solution) or Travatan Z® (Travoprost Ophthalmic Solution) on Ocular Surface Signs and Symptoms in Ocular Hypertensive or Glaucoma Patients: An Exploratory Study

M. B. McDonald; E. D. Donnenfeld; H. D. Perry; G. D'Aversa; M. A. Swerdin; D. M. Sachs; J. R. Wittpenn, Jr.; J. K. Oats; R. E. Mariani; P. R. Galstian

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4652.

ARVO Annual Meeting Abstract May 2007

The Effect of Decreasing Cyclosporine 0.05% on Dry Eye Disease After One Year of Therapy

M. Y. Su; H. D. Perry; E. D. Donnenfeld; J. R. Wittpenn

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):374.

ARVO Annual Meeting Abstract May 2007

Subclinical CME Reduces Contrast Sensitivity and Final Visual Acuity in Low Risk Cataract Patients

J. R. Wittpenn; S. Silverstein; J. Hunkeler; K. Kenyon; ACME Study Group

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5464.

Advertisement